Serena Cardillo, MD

faculty photo
Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
Attending, Hospital of the University of Pennsylvania
Director of Graduate Diabetes Education, Penn Rodebaugh Diabetes Center, Penn Rodebaugh Diabetes Center
Director of Education, Endocrine, Diabetes & Metabolism, Perelman School of Medicine, University of Pennsylvania
Program Director, Endocrinology, Diabetes and Metabolism Fellowship, Perelman School of Medicine at the University of Pennsylvania
Department: Medicine

Contact information
University of Pennsylvania Perelman School of Medicine
Division of Endocrinology, Diabetes and Metabolism
Perelman Center for Advanced Medicine, West Pavilion, 4th Floor
3400 Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-662-2468
Education:
B.A. (Behavioral Biology)
Johns Hopkins University, 1997.
M.D.
University of Pennsylvania Perelman School of Medicine, 2001.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Cardillo joined the faculty in the Division of Endocrinology, Diabetes, & Metabolism as an Assistant Professor of Medicine in 2006. She completed her undergraduate studies at Johns Hopkins University where she received a B.A. in Behavioral Biology. She received her M.D. from the University of Pennsylvania and completed both a residency in Internal Medicine and a fellowship in Endocrinology at the Hospital of the University of Pennsylvania. Her clinical interests include diabetes management, transplant associated diabetes, pre-diabetes and metabolic syndrome and diabetes in bariatric surgery patients. Her clinical practice is based at the Penn Rodebaugh Diabetes Center.

Description of Other Expertise

Dr. Cardillo is also actively involved in medical education at the residency and fellowship levels. She is currently the Director of Ambulatory Training for the Internal Medicine Residency Program and the Director of Graduate Diabetes Education.

Selected Publications

R Benson Jones Jr, Cori Maskart, Janice Radway, Anastassia Amaro, Serena Cardillo: A Multimodal Curriculum to Improved Medical Student Gender-Affirming Communication Skills. Poster Presentation Endocrine Society 2023.

Nnenia Francis, Serena Cardillo, Deepa Nandiwada: Exploring Primary Care Residents Perspectives on Diabetes Education in Training. Poster Presentation Endocrine Society 2023.

Heath J, Dine CJ, Lamarra D, Cardillo S: The Impact of Trainee and Standardized Patient Race and Gender on Internal Medicine Resident Communication Assessment Scores. Journal of Graduate Medical Education 13(5): 643-649, 2021 Notes: doi:10.4300/JGME-D-21-00106.1.

Caitlin White MD, Serena Cardillo MD: Introduction of an Ambulatory Curriculum in Endocrinology Diabetes and Metabolism for Internal Medicine Trainees. Poster Presentation, Endocrine Society March 2020.

Janae Heath, c. Jessica Dine, Denise Lamarra, Serena Cardillo: Impact of Trainee and Standardized Patient Gender on Communication Assessment Scores. APDIM Online 2020 2020 Notes: Poster.

Caitlin A White, MD1; Paul Guido, MD2; Laura Young, MD, PhD2; Serena Cardillo, MD1: Redesigning Fellowship Curriculum Amidst The Covid-19 Pandemic: Our Shared Experiences. Endocrine Practice 26(8): 926-928, 2020 Notes: doi:10.4158/EP-2020-0365.

M Elle Saine, Dena M Carbonari, Craig W Newcomb, Arlene M Gallagher, Betina T Blak, Jason A Roy, Jennifer Wood, Serena Cardillo, Sean Hennessy 1, Brian L Strom, Vincent Lo Re 3rd: Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies. Pharmacoepidemiol Drug Safety 28(10): 1328-1335, 2019 Notes: doi:10.1002/pds.4853.

Rahul Agarwal MD and Serena Cardillo MD: Successful Long-Term Treatment of Hyperinsulinemic Hypoglycemia Using a Monthly Somatostatin Receptor Analog in a 91 Year Old Patient Poster Presentation, Endocrine Society March 2018.

Leonard CE, Han X, Brensinger CM, Bilker WB, Cardillo S, Flory JH, Hennessy S.: Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study. Pharmacoepidemiol Drug Saf. 27(1): 9-18, January 2018.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.: Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes BMJ Open Diabetes Research and Care 5(1), July 2017.

back to top
Last updated: 09/18/2023
The Trustees of the University of Pennsylvania